Post-Ensartinib Outcomes in Refractory Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

被引：1
|
作者：
Kim, H. [1 ]
Vu, P. [2 ]
Harrow, K. [3 ]
Liang, C. [4 ]
Selvaggi, G. [3 ]
Weihe, E. [2 ]
Mitchell, W. [2 ]
Bazhenova, L. [2 ]
Patel, S. [2 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
[3] Xcovery Holdings Inc, Palm Beach Gardens, AL USA
[4] Xcovery Holdings Inc, Palm Beach Gardens, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; ALK; ensartinib;
D O I：
10.1016/j.jtho.2019.08.1208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.14-57
引用
收藏
页码：S577 / S578
页数：2
相关论文
共 50 条
  • [31] Integrated biomarker analysis of brigatinib efficacy in anaplastic lymphoma kinase-positive (ALK plus ) non-small cell lung cancer (NSCLC) refractory to alectinib
    Ou, S-H. I.
    Nishio, M.
    Yoshida, T.
    Ahn, M-J.
    Mok, T. S. K.
    Kudou, K.
    Asato, T.
    Yang, H.
    Tong, X.
    Zhang, P.
    Yamamoto, N.
    Kim, E. S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1014 - S1015
  • [32] Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer
    Awad, Mark M.
    Mastini, Cristina
    Blasco, Rafael B.
    Mologni, Luca
    Voena, Claudia
    Mussolin, Lara
    Mach, Stacy L.
    Adeni, Anika E.
    Lydon, Christine A.
    Sholl, Lynette M.
    Janne, Pasi A.
    Chiarle, Roberto
    ONCOTARGET, 2017, 8 (54) : 92265 - 92274
  • [33] Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
    Liu, Jingru
    Ma, Shutao
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (06) : 590 - 613
  • [34] SYSTEMATIC LITERATURE REVIEW (SLR) OF SEQUENCING OF ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITORS IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
    Barrows, S. M.
    Wright, K.
    Copley-Merriman, C.
    Kaye, J. A.
    Chioda, M. D.
    Wiltshire, R.
    Torgersen, K. M.
    Masters, E. T.
    VALUE IN HEALTH, 2018, 21 : S49 - S50
  • [35] Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): Results of a multi-centre ALK-testing
    Laffert, Maximilian V.
    Warth, Arne
    Penzel, Roland
    Schirmacher, Peter
    Jonigk, Danny
    Kreipe, Hans
    Schildhaus, Hans-Ulrich
    Merkelbach-Bruse, Sabine
    Buettner, Reinhard
    Reu, Simone
    Kerler, Rosi
    Jung, Andreas
    Kirchner, Thomas
    Woelfel, Cornelius
    Petersen, Iver
    Rodriguez, Regulo
    Jochum, Wolfram
    Bartsch, Holger
    Fisseler-Eckhoff, Annette
    Berg, Erika
    Lenze, Dido
    Dietel, Manfred
    Hummel, Michael
    LUNG CANCER, 2013, 81 (02) : 200 - 206
  • [36] Economic evaluation crizotinib, alectinib and brigatinib in anaplastic lymphoma kinase positive (ALK plus ) non-small cell lung cancer (NSCLC).
    Choi, Briana
    Alkhatib, Nimer S.
    Pae, Elizabeth
    Babiker, Hani M.
    Garland, Linda L.
    Henglefelt, Alyssa
    McBride, Ali
    Abraham, Ivo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Clinical implications and future perspectives in testing non-small cell lung cancer (NSCLC) for anaplastic lymphoma kinase (ALK) gene rearrangements
    Gelsomino, Francesco
    Rossi, Giulio
    Tiseo, Marcello
    JOURNAL OF THORACIC DISEASE, 2015, 7 (03) : 220 - 223
  • [38] Prevalence of Anaplastic Lymphoma Kinase (ALK) plus Non-Small Cell Lung Cancer (NSCLC) in the Middle East and North Africa (MENA)
    Jazieh, A. R.
    Gaafar, R.
    Errihani, H.
    Jaafar, H.
    Al Dayel, F.
    Bahnassy, A.
    El Kadi, H.
    Abdallah, M. Magdy
    Bearz, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S299 - S299
  • [39] Clinicopathologic Features Associated with Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Non-Small Cell Lung Cancer (NSCLC) in Midwestern Population
    Valentine, J.
    Johnson, M.
    Zhang, Y.
    Raj, R.
    Nayar, R.
    Raparia, K.
    LABORATORY INVESTIGATION, 2014, 94 : 497A - 497A
  • [40] Clinicopathologic Features Associated with Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Non-Small Cell Lung Cancer (NSCLC) in Midwestern Population
    Valentine, J.
    Johnson, M.
    Zhang, Y.
    Raj, R.
    Nayar, R.
    Raparia, K.
    MODERN PATHOLOGY, 2014, 27 : 497A - 497A
12345